Publication Name	World Journal of Radiology
Manuscript ID	96833
Country	China

Received	2024-05-16 05:19
Peer-Review Started	2024-05-16 05:21
To Make the First Decision
Return for Revision	2024-08-23 05:22
Revised	2024-09-05 07:35
Second Decision	2024-09-24 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-24 06:21
Articles in Press	2024-09-24 06:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-16 02:06
Publish the Manuscript Online	2024-10-28 07:36

ISSN	1949-8470 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Case Report
Article Title	Successful management of infection and macrophage activation syndrome patient using low-dose etoposide: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Shu-Pei Gao, Xiao-Fang Luo, Mohammadreza Kosari, Wen-Juan Li, Liu Yang, Wei Tu and Ji-Xin Zhong
ORCID	Author(s) ORCID Number Liu Yang http://orcid.org/0000-0001-5371-8807 Wei Tu http://orcid.org/0000-0003-2983-153X Ji-Xin Zhong http://orcid.org/0000-0002-3534-7480
Funding Agency and Grant Number
Corresponding Author	Liu Yang, Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. liuliutree@tjh.tjmu.edu.cn
Key Words	Macrophage activation syndrome; Hemophagocytic lymphohistiocytosis; Infection; Systemic lupus erythematosus; Etoposide; Case report
Core Tip	Etoposide is a first-line drug for the treatment of macrophage activation syndrome (MAS). However, in cases where severe infections and autoimmune disorders are present concurrently, the use of etoposide carries the risk of bone marrow suppression and exacerbation of infections. In this case report, we successfully avoided bone marrow suppression and controlled both MAS and severe infection in patients in such condition by using a modified etoposide regimen.
Publish Date	2024-10-28 07:36
Citation	<p>Gao SP, Luo XF, Kosari M, Li WJ, Yang L, Tu W, Zhong JX. Successful management of infection and macrophage activation syndrome patient using low-dose etoposide: A case report. <i>World J Radiol</i> 2024; 16(10): 579-585</p>
URL	https://www.wjgnet.com/1949-8470/full/v16/i10/579.htm
DOI	https://dx.doi.org/10.4329/wjr.v16.i10.579

Full Article (PDF)	WJR-16-579-with-cover.pdf
CARE Checklist–2016	96833-CARE-Checklist-2016.pdf
Manuscript File	96833_Auto_Edited_033617.docx
Answering Reviewers	96833-answering-reviewers.pdf
Audio Core Tip	96833-audio.mp3
Conflict-of-Interest Disclosure Form	96833-conflict-of-interest-statement.pdf
Copyright License Agreement	96833-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	96833-foundation-statement.pdf
Signed Consent for Treatment Form(s) or Document(s)	96833-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	96833-non-native-speakers.pdf
Supplementary Material	96833-supplementary-material.pdf
Peer-review Report	96833-peer-reviews.pdf
Scientific Misconduct Check	96833-scientific-misconduct-check.png
Scientific Editor Work List	96833-scientific-editor-work-list.pdf
CrossCheck Report	96833-crosscheck-report.pdf